-+ 0.00%
-+ 0.00%
-+ 0.00%

Opaleye Management reports acquisition of $83,435.0168 in Grace Therapeutics common shares

PUBT·11/19/2026 01:35:53
Listen to the news
Opaleye Management reports acquisition of $83,435.0168 in Grace Therapeutics common shares
  • Opaleye Management, a 10% owner of Grace Therapeutics, purchased 48,060 shares of common stock.
  • Indirect beneficial ownership through Opaleye, L.P. rose to 3,102,904 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grace Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-053120), on November 18, 2026, and is solely responsible for the information contained therein.